Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies. (2015)
Attributed to:
EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/biot.201400348
PubMed Identifier: 25524780
Publication URI: http://europepmc.org/abstract/MED/25524780
Type: Journal Article/Review
Volume: 10
Parent Publication: Biotechnology journal
Issue: 1
ISSN: 1860-6768